ThirdLaw Molecular is developing a new class of
Author: Michael
Trial aims to demonstrate capacity to extend hea
Landmark conference concludes with call for unif
ARMMs technology expands scope of potential epig
Research highlights role of C15:0 in cellular re
Company says senolytic therapeutic delivers ‘r
Startup boasts pipeline of candidates targeting
Participants saw gains in strength, immune funct
Human Longevity pledges $1 million for advanced
TruDiagnostic Founder Ryan Smith on personalized